Scientific Industries Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Scientific Industries Inc 's ROA in the second quarter of 2026?
Scientific Industries Inc recorded a cumulative net loss of $-1 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -9.5%.

However, within the Healthcare sector 297 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3307, from total ROA ranking in the first quarter of 2026 at 3916.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	62.11 %	5.05 %	12.79 %	9.4 %	-28.36 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-1	-2	-2	-1	-6
Return On Assets (TTM)	-9.5 %	-13.12 %	-14.85 %	-10.63 %	-56.64 %
SCND's Total Ranking	# 3307	# 3916	# 3302	# 4141	# 4149
Total Assets (TTM) in million	17	11	13	15	10
Seq. Total Assets Change	49.31 %	-11.93 %	-13.39 %	42.35 %	-3.25 %
Seq. Net Income Change	-	-	-	-	-

SCND's 5 Years Annual ROA >> Back to SCND Management Effectiveness >> Compare SCND ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 13
Sector	# 298
Overall	# 3192

Return On Assets Statistics
High	Average	Low
40.48 %	-11.81 %	-60.23 %
(Jun 30 2014)		(Dec 31 2023)

Financial Statements
Scientific Industries Inc 's Assets	$ 17 million	SCND's Balance sheet
Scientific Industries Inc 's Income	$ -1 million	Quarterly SCND's Income Statement
SCND's Income by Division		See SCND's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Jun 30 2022) FY 2022	(Jun 30 2021) FY 2020
Y / Y Total Assets Change	12.44 %	-36.59 %	-44.83 %	-0.33 %	96.02 %
Total Assets in million	11	10	16	29	29
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-2	-6	-9	-6	-4
Annual Return On Assets	-15.65 %	-63.73 %	-56.97 %	-19.52 %	-12.66 %

SCND's 5 Years Annual ROA >> Back to SCND Management Effectiveness >> Compare SCND ROA to its Competitors

More Return On Assets Ratios
SCND's' Return on Assets at Yahoo Finance
Laboratory Analytical Instruments Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SCND's Roa Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SCND's Competitors
Subscribers only: Roa for Scientific Industries Inc 's Suppliers
Subscribers only: Return On Assets for SCND's Customers

You may also want to know
SCND's Roi	SCND's Inventory Turnover Ratio	SCND's Growth Rates	SCND's Dividend Comparisons
	SCND's Profitability Ratios	SCND's Asset Turnover Ratio	SCND's Dividend Growth
SCND's Roe	SCND's Valuation Ratios	SCND's Financial Strength Ratios	SCND's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-08T22:13:29+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.